|AMC to achieve world-class survival rates of lung transplantation|
|Date : 2017.07.27|
A significant increase in survival rates of lung transplantation to give hope to patients
The AMC lung transplantation team has analyzed 41 patients who underwent lung transplantation between 2008 and the end of last year and found that one-year, three-year, and five-year survival rates are 81.4%, 76.9%, and 65.5%, respectively. This means that two out of every three lung transplantation patients survived for more than five years. This is expected to give hope to patients who are hesitant about transplantation due to lower survival rates than other organ transplantations. AMC’s performance in lung transplantation is greater than that of the Korean Network for Organ Sharing (KNOS) and the International Society for Heart and Lung Transplantation (ISHLT). Professor Park Seung-il of the Department of Thoracic and Cardiovascular Surgery said, “AMC’s survival rates for lung transplantation have reached the global level. This will bring great hope to patients with end-stage lung diseases.” Consequently, lung transplantation will take a step toward becoming a treatment that ensures long-term survival and quality of life to end-stage lung failure patients. The photo shows Professor Kim Dong-kwan of the Department of Thoracic and Cardiovascular surgery (right) performing a lung transplantation.
The AMC lung transplantation team (Professors Park Seung-il and Kim Dong-kwan and Professor Cho Se-hoon of the Department of Thoracic and Cardiovascular Surgery, Professors Shim Tae-sun and Hong Sang-bum of the Department of Pulmonology and Critical Care Medicine, and Professor Lee Sang-oh of the Department of Infectious Disease) has analyzed 41 patients who underwent lung transplantation from 2008 through the end of last year and recently announced that the five-year survival rate is 65.5%, indicating that the survival rate of lung transplantation in Korea has reached the global level. According to the Korean Network for Organ Sharing (KNOS), one-year, three-year, and five-year survival rates of lung transplantation in Korea are 81.4%, 76.9%, and 65.5%, respectively. Meanwhile, the International Society for Heart and Lung Transplantation (ISHLT) reported that one-year, three-year, and five-year survival rates of lung transplantation in the world are 85%, 67%, and 61%, respectively. AMC has achieved an international level of performance.
Korean patients with lung transplantation are more likely than foreign patients to put on a ventilator or an extracorporeal membrane oxygenation (ECMO) machine for a long period of time before transplantation. The lung transplantation team’s high survival rate despite a high frequency of severe patients is attributable to not only accumulated experience in surgery and pre-/post-operative high-quality intensive care, but also the successful multidisciplinary treatment system for lung transplantation patients, including timely and proper response to post-charge complications.
Forty-one patients who received lung transplantation in AMC include 27 men and 14 women. Eleven patients were in their 50s, accounting for 26.8%, with nine in their 40s and seven in their 30s and 70s. The largest number of patients (16) received lung transplantation due to idiopathic pulmonary fibrosis (IPF), in which lung tissues become thick and stiff, causing a decline in lung function. Out of 41 patients, three died prematurely and seven died from infections such as pneumonia and septicemia. There were no deaths from transplant rejection, demonstrating that we are thoroughly caring for patients who experience transplant rejection.
Professor Park Seung-il said, “We are leading the medical world with high survival rates of other organ transplantations, including the liver and heart, but had been trailing in lung transplantation. The study result of increased survival rates in lung transplantation is expected to give hope to end-stage lung disease patients.”
The research result was introduced at the 36th Annual Congress of the Korean Society of Critical Care Medicine (KSCCM), held this year.